Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The incidence rate and mortality of lung infection are high worldwide. It is a common and frequently occurring disease which seriously threatens human health. Severe pneumonia accounts for 18-36% of all pneumonia. Severe pneumonia has caused serious economic and medical burden. Therefore, it is urgent to carry out the real-world cohort study of severe pneumonia. Big data and sample library will provide useful clinical guidance and scientific research reserves for clinicians. Through further research, we can improve the treatment success rate and reduce the mortality.
The purpose of this study is to provide reliable biological samples and related data information for the relevant basic and clinical trials in the field of severe pneumonia by carrying out the construction of special disease cohort database and biological sample holographic database, and to establish a long-term sharing platform for the transformation of research results into clinical practice, improve the prognosis of severe pneumonia,and provide the evidence for improving the diagnosis and treatment of severe pneumonia suitable for China's national conditions.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| severe pneumonia | Patients with severe pneumonia |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| clinical outcome of patients with severe pneumonia | The pneumonia is cured or improved, or the treatment of pneumonia is invalid, or the patient is dead. | day 3, day 7, day 14, day 30, day 180. |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
● Cannot understand and / or implement the investigation protocol.
Not provided
Not provided
Patients of severe pneumonia
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Jieming Qu, MD,PhD | Contact | +86-21-64370045 | jmqu0906@163.com |
| Name | Affiliation | Role |
|---|---|---|
| Jieming Qu, MD,PhD | Ruijin Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Ruijin Hospital, Medical School of Shanghai Jiaotong University | Recruiting | Shanghai | Shanghai Municipality | 200025 | China |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D011014 | Pneumonia |
| ID | Term |
|---|---|
| D012141 | Respiratory Tract Infections |
| D007239 | Infections |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
intravenous blood, sputum, urine, bronchoalveolar lavage fluid and pleural effusion